NCATS
Spinoff Company to Develop Rare Disease Drugs
Spinoff Company to Develop Rare Disease Drugs
Molly Sharlach | Jan 7, 2015
Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.
Mining Existing Drugs for Ebola Treatments
Mining Existing Drugs for Ebola Treatments
Rina Shaikh-Lesko | Dec 17, 2014
Researchers hope to repurpose already-approved drugs into potential anti-Ebola therapies.
NIH to Resurrect Old Drugs
NIH to Resurrect Old Drugs
Chris Palmer | Jun 20, 2013
Academic scientists and the pharmaceutical industry will collaborate on a new program to speed up the drug development process.